Mojun Zhao Selected Research

urtoxazumab

1/2017

Efficacy of Urtoxazumab (TMA-15 Humanized Monoclonal Antibody Specific for Shiga Toxin 2) Against Post-Diarrheal Neurological Sequelae Caused by Escherichia coli O157:H7 Infection in the Neonatal Gnotobiotic Piglet Model.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mojun Zhao Research Topics

Disease

2	Neoplasms (Cancer) 12/2017 - 04/2007
2	Infections 01/2017 - 09/2008
2	Weight Loss (Weight Reduction) 03/2013 - 10/2012
2	Diarrhea 03/2013 - 01/2013
1	Body Weight (Weight, Body) 01/2017
1	Infarction (Infarctions) 01/2017
1	Necrosis 01/2017
1	Weight Gain 01/2017
1	Canavan Disease (Leukodystrophy, Spongiform) 03/2016
1	Nervous System Diseases (Neurological Disorders) 03/2016
1	Cholera 01/2013
1	Multiple Myeloma 04/2007

Drug/Important Bio-Agent (IBA)

2	AntigensIBA 03/2013 - 04/2007
2	Enterotoxins (Enterotoxin)IBA 03/2013 - 09/2008
2	Proteins (Proteins, Gene)FDA Link 01/2013 - 10/2012
1	S-Adenosylmethionine (Ademetionine)IBA 12/2017
1	Adenosine Triphosphate (ATP)IBA 12/2017
1	Methionine (L-Methionine)FDA Link 12/2017
1	Methionine AdenosyltransferaseIBA 12/2017
1	Anti-Infective Agents (Microbicides)IBA 12/2017
1	EnzymesIBA 12/2017
1	Shiga Toxin 2IBA 01/2017
1	urtoxazumabIBA 01/2017
1	Monoclonal AntibodiesIBA 01/2017
1	Shiga Toxin (Shigella Toxin)IBA 01/2017
1	N-acetylaspartate (N-acetyl aspartate)IBA 03/2016
1	Subunit VaccinesIBA 03/2013
1	Cholera ToxinIBA 01/2013
1	A-factor (Streptomyces)IBA 04/2007
1	MHC class II transactivator proteinIBA 04/2007